Companies
SNY
Sanofi
$46.58-11.47%1Y
SNY · daily close · illustrative · 0 catalysts marked
Pipeline
Phase 2Plasma Cell Myeloma Refractory
Phase 3Plasma Cell Myeloma
Phase 2Relapsed Refractory Multiple Myeloma
Phase 3Multiple Sclerosis
Phase 3Fabry Disease
Phase 3Fabry Disease
Phase 3Dermatitis Atopic
Phase 2Asthma
Phase 2Coeliac Disease
Phase 2Celiac Disease
Phase 2Alopecia Areata
Phase 3Hemophilia
Phase 3Glycogen Storage Disease Type II
Phase 3Lung Transplant Rejection
Phase 2Chronic Graft-versus-host-disease
Phase 2Plasma Cell Myeloma Refractory
Phase 3Lung Transplant Rejection
Phase 3Plasma Cell Myeloma
Phase 3Multiple Sclerosis
Phase 3Hemophilia
Phase 3Plasma Cell Myeloma
Phase 3Non Small Cell Lung Cancer Metastatic
Phase 3Pruritus
Phase 3Wheezing
Phase 3Asthma
Phase 3Lichen Simplex Chronicus
Phase 3Prurigo Nodularis
Phase 2Colitis Ulcerative
Phase 3Hemophilia A
Phase 3Pruritus
Phase 3Hemophilia
Phase 2/3Kidney Transplant Rejection
Phase 2Type 1 Diabetes Mellitus
Phase 3Multiple Sclerosis
Phase 2Focal Segmental Glomerulosclerosis
Phase 2Glomerulonephritis Minimal Lesion
Phase 3Immunoglobulin G4 Related Disease
Phase 3Pneumococcal Immunization
Phase 3Pneumococcal Immunization
Phase 3Plasma Cell Myeloma Recurrent
Phase 3Plasma Cell Myeloma
Phase 3Plasma Cell Myeloma Recurrent
Phase 3Chronic Rhinosinusitis With Nasal Polyps
Phase 3Chronic Obstructive Pulmonary Disease
Phase 3Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3Chronic Obstructive Pulmonary Disease
Phase 2Asthma
Phase 2Chronic Rhinosinusitis With Nasal Polyps
Phase 3Pneumococcal Immunization
Phase 3Yellow Fever Immunization
Phase 3Meningococcal Infection
Phase 3Healthy Volunteers
Phase 2Meningococcal Immunization
Phase 3Meningococcal Immunisation
Phase 3Healthy Volunteers
Phase 3Plasma Cell Myeloma
Phase 3Fabry Disease
Phase 3Chronic Rhinosinusitis With Nasal Polyps
Phase 3Plasma Cell Myeloma
Phase 3Multiple Sclerosis
Phase 3Multiple Sclerosis
Phase 3Plasma Cell Myeloma Recurrent
Phase 3Chronic Graft-versus-host-disease
Phase 3Pneumococcal Immunization
Phase 3Pneumococcal Immunization
Phase 3Polyneuropathy, Inflammatory Demyelinating, Chronic
Phase 3Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3Immune Thrombocytopenia
Phase 3Autoimmune Haemolytic Anaemia
Phase 2Warm Autoimmune Hemolytic Anemia (wAIHA)
Phase 3Immunoglobulin G4 Related Disease
Phase 2Focal Segmental Glomerulosclerosis
Phase 2Glomerulonephritis Minimal Lesion
Phase 3Sickle Cell Disease
Phase 3Pneumococcal Immunization
Phase 3Pneumococcal Immunization
Phase 3Non Small Cell Lung Cancer Metastatic
Phase 3Type 1 Diabetes Mellitus
Phase 3Relapsing Multiple Sclerosis
Phase 3Secondary Progressive Multiple Sclerosis (SPMS)
Phase 3Progressive Relapsing Multiple Sclerosis
Phase 3Multiple Sclerosis
Phase 3Relapsing Multiple Sclerosis
Phase 3Secondary Progressive Multiple Sclerosis (SPMS)
Phase 3Progressive Relapsing Multiple Sclerosis
Phase 3Dermatitis Atopic
Phase 3Dermatitis Atopic
Phase 3Pneumococcal Immunization
Phase 3Pneumococcal Immunization
Phase 3Pneumococcal Immunization
Phase 3Gaucher's Disease Type III
Phase 3Yellow Fever Immunization
Phase 2Plasma Cell Myeloma Refractory
Phase 2/3Kidney Transplant Rejection
Phase 2Relapsed Refractory Multiple Myeloma
Phase 2/3Kidney Transplant Rejection
Phase 2/3Kidney Transplant Rejection
Phase 2/3Kidney Transplant Rejection
Phase 2Acne
Phase 2Solid Tumor
Phase 2Glycogen Storage Disease Type II-Pompe's Disease
Phase 2Transplant Rejection
Phase 2Glycogen Storage Disease Type II-Pompe's Disease
Phase 2Plasma Cell Myeloma Refractory
Phase 2Solid Tumor
Phase 2Transplant Rejection
Phase 2Usher's Syndrome
Phase 2Hidradenitis Suppurativa
Phase 2Type 1 Diabetes Mellitus
Phase 2Focal Segmental Glomerulosclerosis
Phase 2Glomerulonephritis Minimal Lesion
Phase 2Asthma
Phase 2Asthma
Phase 2Plasma Cell Myeloma Refractory
Phase 2Plasma Cell Myeloma
Phase 2Relapsed Refractory Multiple Myeloma
Phase 2Plasma Cell Myeloma
Phase 2Solid Tumor
Phase 2Chlamydia Trachomatis Immunization
Phase 2Transplant Rejection
Phase 2Plasma Cell Myeloma Refractory
Phase 2Plasma Cell Myeloma
Phase 2Relapsed Refractory Multiple Myeloma
Phase 2Relapsed Refractory Multiple Myeloma
Phase 2Neovascular Age-Related Macular Degeneration (nAMD)
Phase 2Plasma Cell Myeloma Refractory
Phase 2Asthma
Phase 2Type 1 Diabetes Mellitus
Phase 2Transplant Rejection
Phase 2Human Metapneumovirus Immunization
Phase 2Respiratory Syncytial Virus Immunization
Phase 2Human Metapneumovirus Immunization
Phase 2Respiratory Syncytial Virus Immunization
Phase 2Human Metapneumovirus Immunization
Phase 2Respiratory Syncytial Virus Immunization
Phase 2Human Metapneumovirus Immunization
Phase 2Respiratory Syncytial Virus Immunization
Phase 2Solid Tumor
Phase 2Plasma Cell Myeloma
Phase 2Plasma Cell Myeloma Refractory
Phase 2Plasma Cell Myeloma
Phase 2Plasma Cell Myeloma
Phase 2Human Metapneumovirus Immunization
Phase 2Respiratory Syncytial Virus Immunization
Phase 2Stargardt's Disease
Phase 2Transplant Rejection
Phase 2Solid Tumor
Phase 2Plasma Cell Myeloma Refractory
Phase 2Graves' Disease
Phase 2Graves' Disease
Phase 2Transplant Rejection
Phase 2Neovascular Age-Related Macular Degeneration (nAMD)
Phase 2Plasma Cell Myeloma Refractory
Phase 2Colitis Ulcerative
Phase 2Microscopic Colitis
Phase 2Phenylketonuria
Phase 2Hidradenitis Suppurativa
Phase 2Solid Tumor
Phase 2Myotonic Dystrophy
Phase 2Geographic Atrophy
Phase 2Juvenile Idiopathic Arthritis
Phase 2Geographic Atrophy
Phase 2Asthma
Phase 2Influenza
Phase 2Healthy Volunteers
Phase 2Yellow Fever
Phase 2Healthy Volunteers
Catalyst Calendar
No catalyst events on record for yet. Check back after the next daily ingest.